Pimivalimab
Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor[1].
Product Specifications
CAS Number
2293951-22-9
Product Name Alternative
JTX-4014
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pimivalimab.html
Purity
97.87
Solubility
10 mM in DMSO
Smiles
[Pimivalimab]
Molecular Weight
(144.9 kDa)
References & Citations
[1]K. Papadopoulos, et al. 172P Phase I study of JTX-8064, a LILRB2 (ILT4) inhibitor, as monotherapy and combination with pimivalimab (pimi), a PD-1 inhibitor (PD-1i), in patients (pts) with advanced solid tumors. VOLUME 16, SUPPLEMENT 1, 100284, DECEMBER 01, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N001280 30 Pack (30 Marker (s) x 1 Roll)
HAUTEPRESS.355X37RL-T1-LL-P14 Pipe Markers for Steam
Sign In for Pricing
View Details 
129618-HRP 100 µL
MGAT4A (Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, GlcNAc-T IVa, GNT-IV, GnT-Iva, GnT-IVa, GNT-IVA, N-acetylglucosaminyltransferase IVa, N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa, Mannosyl (alpha-1,3-) -glycoprotein beta-1,4-N-acetylglucosaminyltransferase, Isozyme A) (HRP)
Sign In for Pricing
View Details 